Health Care & Life Sciences » Healthcare Provision | Hangzhou Tigermed Consulting Co. Ltd.

Hangzhou Tigermed Consulting Co. Ltd. | Mutual Funds

Mutual Funds that own Hangzhou Tigermed Consulting Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Bank of Communications Schroder Select Fund
5,088,865
1.72%
-1,267,557
10.53%
12/31/2017
4,252,723
1.44%
4,252,723
11.24%
12/31/2017
Fidelity Series Emerging Markets Fund
3,873,700
1.31%
3,873,700
0.23%
07/31/2018
3,651,961
1.24%
1,487,920
10.57%
12/31/2017
3,643,652
1.23%
3,643,652
9.61%
12/31/2017
2,798,473
0.95%
2,376,288
1.1%
12/31/2017
Bank of Communications Schroder Pioneer Fund
2,384,299
0.81%
-39,647
15.65%
12/31/2017
2,142,763
0.73%
0
5.66%
12/31/2017
2,083,021
0.71%
96,679
14.95%
12/31/2017
Fidelity International Discovery Fund
1,952,549
0.66%
0
0.16%
07/31/2018

About Hangzhou Tigermed Consulting Co.

View Profile
Address
15th floor
Hangzhou Zhejiang 310053
China
Employees -
Website http://www.tigermed.net
Updated 07/08/2019
Hangzhou Tigermed Consulting Co., Ltd. provides clinical research services for research and development of domestic and foreign pharmaceutical and health related products. Its services include technical services for phase I to phase IV clinical trials, registration and declaration of clinical trials, on-site services, as well as data management and analysis, etc. The company was founded on December 15, 2004 and is headquartered in Hangzhou, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.